MapLight Therapeutics, Inc. Common Stock (MPLT) — Defensive Interval Ratio
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Defensive Interval Ratio of 5811 days as of December 2025. Defensive assets of $258.37 Million (cash $-, short-term investments $258.37 Million, receivables $-) cover 5811 days of daily cash needs of $44.46K/day. See how liquid is MapLight Therapeutics, Inc. Common Stock's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
MapLight Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how MapLight Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 5811 days, meaning defensive assets of $258.37 Million can fund 5811 days of operations without new revenue. See net asset quality index of MapLight Therapeutics, Inc. Common Stock to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for MapLight Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for MapLight Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MPLT company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5811 days | $258.37 Million | $44.46K/day | $- | $258.37 Million | ▲ +4194 days |
| 2024 | 1617 days | $70.54 Million | $43.62K/day | $- | $70.54 Million | — |